← Open Payments lookup

AMANDA VENTIMIGLIA: Open Payments

NPI 1972845998 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$937 in 37 payments from 13 companies in 2025. Trend: 2023 $1,409 · 2024 $1,585 · 2025 $937

Food & beverage: $937
CompanyPaymentsAmount
Kestra Medical Technology Services, Inc.9$165
Bayer Healthcare Pharmaceuticals Inc.2$157
Novartis Pharmaceuticals Corporation2$105
Amgen Inc.6$104
Edwards Lifesciences Corporation2$94
Esperion Therapeutics, Inc.3$75
Novo Nordisk Inc4$63
SCPHARMACEUTICALS INC.2$44
Alnylam Pharmaceuticals Inc.2$40
E.R. Squibb & Sons, L.L.C.2$34

Products named: Assure WCD, Kerendia, LEQVIO, REPATHA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, NEXLETOL, FUROSCIX, AMVUTTRA.

Industry payments across MO — which companies pay providers there.